Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Ultragenyx Pharmaceutical (RARE) Q3 2026 Earnings
RARE
30
Jul
Confirmed
Q4 2025
Q1 2026
Q2 2026
Next
-1.84
-1.59
-1.34
-1.09
Details
Expected EPS
-1.216342
Actual EPS
N/A
Surprise EPS
1.22
Surprise Percent
+100%
Description
Ultragenyx Pharmaceutical (RARE) will report earnings of for Q3 2026 on July 30, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login